North America Data program

In collaboration with industry regulators and stakeholders, PPTA has developed a system that we believe is the best way to present the distribution of core plasma protein therapies in North America.

PPTA North America Data Program

The PPTA North America Data Program is a voluntary manufacturer initiative undertaken in response to drug shortage concerns, and is intended to provide a reliable, nation-wide assessment of the availability of these life-saving therapies in the United States.

PPTA's Web-based system provides aggregate, monthly distribution data for the following categories of plasma protein therapies:

1. Albumin 5%
2. Albumin 25%
3. Immune Globulin (IG)
4. Plasma-Derived Factor VIII
5. Recombinant Factor VIII

The charts can be accessed by clicking on the link to the product category of your choice. Each chart shows a 12 month snapshot consisting of two lines: one plotting the data points for the monthly distribution volume and another to show the data points for the previous 12 month average distribution volume on a rolling basis.

November 2023

Albumin 5% concentration

Albumin 25% concentration

Immune Globulin (Ig)

Plasma-Derived Factor VIII

Recombinant Factor VIII

By clicking Accept all cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.